AAAAAA

   
Results: 1-11 |
Results: 11
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow
Authors: Aboul-Nasr, R O'Brien, S Freireich, EJ Ginsberg, CF Kantarjian, HM Koller, CA Keating, MJ Albitar, M
Citation: R. Aboul-nasr et al., "T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow, LEUK LYMPH, 42(5), 2001, pp. 1023
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
Authors: O'Brien, SM Kantarjian, AM Cortes, J Beran, M Koller, CA Giles, FJ Lerner, S Keating, M
Citation: Sm. O'Brien et al., Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia, J CL ONCOL, 19(5), 2001, pp. 1414-1420
High-dose chemotherapy in high-risk myelodysplastic syndrome - Covariate-adjusted comparison of five regimens
Authors: Beran, M Shen, Y Kantarjian, H O'Brien, S Koller, CA Giles, FJ Cortes, J Thomas, DA Faderl, S Despa, S Estey, EH
Citation: M. Beran et al., High-dose chemotherapy in high-risk myelodysplastic syndrome - Covariate-adjusted comparison of five regimens, CANCER, 92(8), 2001, pp. 1999-2015
AML in the elderly
Authors: Estey, E Cortes, J Beran, M Koller, CA Keating, MJ
Citation: E. Estey et al., AML in the elderly, HEMAT BLOOD, 40, 2001, pp. 621-627
Twelve tips for developing educational multimedia in a community-based teaching hospital
Authors: Koller, CA Frankenfield, JJ Sarley, CA
Citation: Ca. Koller et al., Twelve tips for developing educational multimedia in a community-based teaching hospital, MED TEACH, 22(1), 2000, pp. 7-10
Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings
Authors: Ha, CS Chung, WK Koller, CA Cox, JD
Citation: Cs. Ha et al., Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings, LEUK LYMPH, 32(5-6), 1999, pp. 497-503
Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: Two cases and an update of the literature
Authors: Anderson, CM Bueso-Ramos, CE Wallner, SA Albitar, M Rosenzweig, TE Koller, CA
Citation: Cm. Anderson et al., Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: Two cases and an update of the literature, LEUK LYMPH, 32(3-4), 1999, pp. 385
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia
Authors: Beran, M Estey, E O'Brien, S Cortes, J Koller, CA Giles, FJ Kornblau, S Andreeff, M Vey, N Pierce, SR Hayes, K Wong, GC Keating, M Kantarjian, H
Citation: M. Beran et al., Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia, J CL ONCOL, 17(9), 1999, pp. 2819-2830
Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
Authors: Sacchi, S Kantarjian, HM O'Brien, S Cortes, J Rios, MB Giles, FJ Beran, M Koller, CA Keating, MJ Talpaz, M
Citation: S. Sacchi et al., Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients, CANCER, 86(12), 1999, pp. 2632-2641
A Phase I-II trial of escalating doses of mitoxantrone with fixed doses ofcytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia
Authors: Koller, CA Kantarjian, HM Feldman, EJ O'Brien, S Rios, MB Estey, E Keating, M
Citation: Ca. Koller et al., A Phase I-II trial of escalating doses of mitoxantrone with fixed doses ofcytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia, CANCER, 86(11), 1999, pp. 2246-2251
Results of topotecan single-agent therapy in patients with myelodysplasticsyndromes and chronic myelomonocytic leukemia
Authors: Beran, M Estey, E O'Brien, SM Giles, FJ Koller, CA Kornblau, S Keating, M Kantarjian, HM
Citation: M. Beran et al., Results of topotecan single-agent therapy in patients with myelodysplasticsyndromes and chronic myelomonocytic leukemia, LEUK LYMPH, 31(5-6), 1998, pp. 521-531
Risultati: 1-11 |